छोड़कर सामग्री पर जाएँ
Steel producer Goodluck India Q2 PAT grows 70% to Rs 34 crore

Steel producer Goodluck India Q2 PAT grows 70% to Rs 34 crore

  • द्वारा
  • Latest News

It had clocked a PAT of Rs 20.36 crore during the July-September period of the preceding 2022-23 fiscal, the company said in a statement on Monday.

Read More

​ It had clocked a PAT of Rs 20.36 crore during the July-September period of the preceding 2022-23 fiscal, the company said in a statement on Monday. It had clocked a PAT of Rs 20.36 crore during the July-September period of the preceding 2022-23 fiscal, the company said in a statement on Monday.  Moneycontrol Latest News Read More  

It had clocked a PAT of Rs 20.36 crore during the July-September period of the preceding 2022-23 fiscal, the company said in a statement on Monday.

Apple iPhone 15 Pro Max vs Google Pixel 8 Pro

Apple iPhone 15 Pro Max vs Google Pixel 8 Pro

  • द्वारा
  • Latest News

There was a time when the iPhone had a significant edge in the video department. The last couple of Pixel Pro devices have bridged that gap.

Read More

​ There was a time when the iPhone had a significant edge in the video department. The last couple of Pixel Pro devices have bridged that gap. There was a time when the iPhone had a significant edge in the video department. The last couple of Pixel Pro devices have bridged that gap.  Moneycontrol Latest News Read More  

There was a time when the iPhone had a significant edge in the video department. The last couple of Pixel Pro devices have bridged that gap.

Zydus, Sun Pharma ink licensing pact to co-market CKD treatment drug

Zydus, Sun Pharma ink licensing pact to co-market CKD treatment drug

  • द्वारा
  • Latest News

The companies have entered into a licensing agreement to co-market the innovative drug, Desidustat, in India, Zydus said in a regulatory filing.

Read More

​ The companies have entered into a licensing agreement to co-market the innovative drug, Desidustat, in India, Zydus said in a regulatory filing. The companies have entered into a licensing agreement to co-market the innovative drug, Desidustat, in India, Zydus said in a regulatory filing.  Moneycontrol Latest News Read More  

The companies have entered into a licensing agreement to co-market the innovative drug, Desidustat, in India, Zydus said in a regulatory filing.

Moneycontrol Pro Market Outlook | The recent low can be tested soon 

Moneycontrol Pro Market Outlook | The recent low can be tested soon 

  • द्वारा
  • Latest News

Several technical indicators signal an oversold market due for a bounce back that can last till Diwali. However, next week will be interesting as the market tries to test the recent low

Read More

​ Several technical indicators signal an oversold market due for a bounce back that can last till Diwali. However, next week will be interesting as the market tries to test the recent low Several technical indicators signal an oversold market due for a bounce back that can last till Diwali. However, next week will be interesting as the market tries to test the recent low  Moneycontrol Latest News Read More  

Several technical indicators signal an oversold market due for a bounce back that can last till Diwali. However, next week will be interesting as the market tries to test the recent low

hi_INहिन्दी